Lupin Limited has informed the Exchange about press release dated 22-Sep-2022 titled Lupin Receives Approval from U.S. FDA for Diclofenac Sodium Topical Solution USP, 2% w/w.
Press Release Sep 22 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Sep 13 2022
- Press Release Sep 09 2022
- Press Release Sep 07 2022
- Press Release Aug 29 2022
- Press Release Aug 26 2022
Later from Lupin
- Press Release Sep 29 2022
- Press Release Oct 01 2022
- Press Release Oct 04 2022
- Press Release Oct 06 2022
- Press Release Oct 07 2022
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin